NCT02575794 2023-10-06
Terameprocol in Treating Patients With Recurrent High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
Clinical Trials
5 trialsNCT00057512 2016-02-23
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Erimos Pharmaceuticals
Phase 1 Completed
NCT00664586 2016-02-23
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
Erimos Pharmaceuticals
Phase 1 Terminated
NCT00664677 2016-02-23
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia
Erimos Pharmaceuticals
Phase 1 Terminated
NCT00259818 2008-01-24
Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
Erimos Pharmaceuticals
Phase 1 Completed